Stenocare AS (OCSE:STENO) Moat Score: 0/10 (As of Jul. 11, 2026)


OCSE:STENO Stenocare AS OCSE:STENO
49 GF Score
Price kr1.00
GF Value kr2.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS Moat Score?

Stenocare AS has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Stenocare AS has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Stenocare AS might have No Moat - No discernible moat.

Stenocare AS  (OCSE:STENO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Stenocare AS Moat Score Related Terms

OCSE:STENO
49GF Score
Stenocare AS OCSE:STENO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stenocare AS (OCSE:STENO) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of kr1.00 is trading 56.7% below its estimated GF Value™ of kr2.31. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for OCSE:STENO:

  • Moat Score: 0
  • GF Value™: kr2.31 vs. price of kr1.00 (56.7% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the OCSE:STENO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges S7C:Germany
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
49GF Score

Get the complete analysis for OCSE:STENO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.00
Price
kr2.31
GF Value